Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

COMBINATION_PRODUCT(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04467671Phase 2Recruiting
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Cardiovascular AbnormalitiesCardiovascular DiseasesDILV - Double Inlet Left Ventricle+8 more
StudychairStart date: 2020-07-15

Research Network

Collaboration Network

5 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mark Galantowicz, MD

Nationwide Children's Hospital

Very Similar
2 trials

Shared therapeutic areas:

Cardiovascular AbnormalitiesCardiovascular DiseasesDILV - Double Inlet Left Ventricle+8 more

Worked with same sponsors:

Gunze LimitedNational Heart, Lung, and Blood Institute (NHLBI)+2 more
Collaborated on 1 trial
Similarity Score114%

Toshiharu Shinoka, MD/PhD

Nationwide Children's Hospital

Very Similar
1 trials

Shared therapeutic areas:

Cardiovascular AbnormalitiesCardiovascular DiseasesDILV - Double Inlet Left Ventricle+8 more

Worked with same sponsors:

Gunze LimitedNational Heart, Lung, and Blood Institute (NHLBI)+2 more
Collaborated on 1 trial
Similarity Score114%

Randall Starling, MD

The Cleveland Clinic

Related
5 trials

Shared therapeutic areas:

Cardiovascular DiseasesHeart Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score5%

Mehwish Waseem, MSPT(CPPT)

Riphah International University

Related
15 trials

Shared therapeutic areas:

Heart Defects, CongenitalHeart Diseases
Similarity Score5%

David Kandzari, MD

Piedmont Heart Institute

Related
12 trials

Shared therapeutic areas:

Cardiovascular DiseasesHeart Diseases
Similarity Score5%

Gao Wei, MD, Phd

Peking University Third Hospital

Related
1 trials

Shared therapeutic areas:

Cardiovascular Diseases
Similarity Score3%

Kevin Volpp, MD, PhD

University of Pennsylvania

Related
12 trials

Shared therapeutic areas:

Cardiovascular Diseases

Worked with same sponsors:

National Institutes of Health (NIH)
Similarity Score3%

Zhaoping Li, MD, PhD

University of California, Los Angeles

Related
17 trials

Shared therapeutic areas:

Cardiovascular Diseases

Worked with same sponsors:

National Institutes of Health (NIH)
Similarity Score3%

Penny M Kris-Etherton, PhD

Penn State University

Related
13 trials

Shared therapeutic areas:

Cardiovascular Diseases
Similarity Score3%

Amir Lerman, MD

Mayo Clinic

Related
15 trials

Shared therapeutic areas:

Cardiovascular Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institutes of Health (NIH)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04467671Phase 2StudyChair

Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts

Cardiovascular AbnormalitiesCardiovascular DiseasesDILV - Double Inlet Left Ventricle+8 more
Recruiting

All 1 trials loaded